Log In
BCIQ
Print this Print this
 

CD3

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting CD3

BCIQ
Print ChartPrint this
0 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1 9 1 6 0 2 1 0 1 0 1 0 0 0
Phases of DevelopmentDiscoveryPreclinicalINDPhase IPhase I/IIPhase IIMarketed
Autoimmune

0

1

0

1

0

0

0

Cancer

1

9

1

6

0

2

1

Endocrine / Metabolic

0

0

0

0

0

1

0

Hematology

0

1

0

0

0

0

0

Hepatic

0

0

0

0

0

1

0

Inflammation

1

0

0

0

0

0

0

Ophthalmic

0

0

0

1

0

0

0

Transplant

0

0

0

0

1

0

0




 Products Targeting CD3
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

7

$1,983.0M

$95.6M

$1,738.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today